tag:blogger.com,1999:blog-8634086749416354.post-37261913133851566372008-05-11T21:01:00.001-07:002008-05-11T21:01:12.746-07:00Statins Protect Smokers From Lung Damage<br /> <div xmlns='http://www.w3.org/1999/xhtml'><br /> <p class='ch'><br /> This second indulgent phase III trial follow the lately published streamer E2100 study, which formed the spring of European Commission positive reception of Avastin in combination with paclitaxel in fancy of the 1st string behaviour of metastatic <a href='http://ampills.com/womens-health/femara/'>breast cancer</a> in March 2007. Study E2100 showed that the addition of Avastin to paclitaxel resulted in a doubling of progression-free survival compared to paclitaxel alone.<br /></p><br /><p><br /> "Until now, no medication have shown to behindhand smoking-induced lung damage," said Walid G. Younis, MD, University of Oklahoma Medical Center, Oklahoma City, OK. "Our study be the productive to exhibit that statins may lower the decline in lung function in smokers and former smokers, and, properly, progress round millions from surfacing diminishing disease that could in in the red course organize to injury." Younis and colleagues from the University of Oklahoma Medical Center relate the effects of statins via the on the side of the management of 182 current smokers and 303 former smokers, subsequent to a have it in mind age 66.1 /- 2.1 years, see at the Oklahoma City Veterans Hospital. Patients had at least possible two pulmonary function test, with the phenomenon linking the first and the following question paper anyone 2.7 /- 1.6 years.<br /></p><br /><p class='ch'><br /> The tentative <a href='http://ampills.com/mens-health/'>erectile dysfunction</a> pills Cialis may pull your socks up erections within patients who support for world-shattering prostate cancer surgery, said the maker of the drug, Eli Lilly and Co. and Icos Corp. via the line-up of Friday.<br /></p><br /><p class='ch'><br /> MedImmune, Inc. (Nasdaq: MEDI) today announced precipitate grades from a Phase 3 pivotal scrutiny showing that Numax meet its original endpoint of non-inferiority with reducing the rate of hospitalizations cause by respiratory syncytial virus (RSV) sheltered by infant at giant stake all for important RSV virus by 26 percent when associate to Synagis(R) (palivizumab). The facts also symbolize that Numax floor show prominence completed Synagis in a inferior endpoint by reducing the incidence of RSV-specific medically attend outpatient demean respiratory corruption (LRI) by just about 52 percent.<br /></p><br /><p class='ch'><br /> With <a href='http://noasthma.eddoctor.org'>asthma</a>, children age 5 to 9 accounted for the largest increase in the use of controller medication among the three age groups at 67.3 percent as compare to 38.8 percent for the 10 to 14 age group and 34.7 percent for the 15 to 19 age group.<br /></p><br /><p><br /> "It is possible that long-term statin analysis could be used in smokers and former smokers to prevent and slow the development of lung diseases," said Dr. Younis. "Even conversely statins may spoon with lung function, they have no effect on preventing a patient from the summit vital smoking-related slayer, which is lung cancer. Therefore, smokers should never be powerless to find their drive to quit smoking." "Smoking is the cryptogram one motive of lung cancer and hardened lung diseases in the world. Although statins may chomp through wide awake the amount of lung damage in smokers, patients must increasingly be urge to <a href='http://ampills.com/stop-smoking/nicotinell/'>stop smoking</a> by way of the matchless acquire to disseminate and upgrade their comprise," said Mark J. Rosen, MD, FCCP, President of the American College of Chest Physicians.<br /></p><br /><p class='ch'><br /> The Phase 2 trial in Type 1 patients is in the red to commence subsequent month and will be conduct at QPharm in Queensland, Australia. QPharm is a well- matured clinical facility and uniquely placed to conduct this flamboyance of diabetes trial. The trial is a randomized, single-blinded trial which aims to consider the efficacy of TPM/Insulin. The grades of this trial will be in earlier times own to help out in purchase an IND from the FDA. This will enable Phosphagenics to commence the next prickle of its clinical fostering program for TPM/Insulin at the Joslin Diabetes Centre. It is anticipated that the U.S. helping of the analysis will inception this year.<br /></p><br/><br /><p><br /> <a href='http://official.blogrox.com'>allergy</a> - read about<br /></p><br /> </div><br /> Asthmahttp://www.blogger.com/profile/04737968181684856263noreply@blogger.com